iRGD‐Targeted Physalis Mottle Virus Like Nanoparticles for Targeted Cancer Delivery

Nanomedicine provides a promising platform for the molecular treatment of disease. An ongoing challenge in nanomedicine is the targeted delivery of intravenously administered nanoparticles to particular tissues, which is of special interest in cancer. Herein, the conjugation of iRGD peptides is show...

Full description

Bibliographic Details
Published in:	Small Science
Main Authors:	Krister J. Barkovich, Zhongchao Zhao, Nicole F. Steinmetz
Format:	Article
Language:	English
Published:	Wiley-VCH 2023-08-01
Subjects:	cancer doxorubicin drug delivery iRGD nanomedicine plant viruses
Online Access:	https://doi.org/10.1002/smsc.202300067

Similar Items

Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model
by: Zheng-Hong Peng, et al.
Published: (2022-08-01)

Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide
by: Gye Lim Kim, et al.
Published: (2023-02-01)

iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
by: Yanbing Dong, et al.
Published: (2023-03-01)

Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth
by: Yu Zhou, et al.
Published: (2019-12-01)

iRGD-Targeted Biosynthetic Nanobubbles for Ultrasound Molecular Imaging of Osteosarcoma
by: Liu T, et al.
Published: (2025-01-01)

Preparation and characterization of a iRGD-modified recombinant spider silk particles for antitumor polypeptide drug delivery into cancer cells
by: Ben Wang, et al.
Published: (2025-08-01)

Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide
by: Eltayeb E. M. Eid, et al.
Published: (2019-07-01)

Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells
by: Anna Egorova, et al.
Published: (2020-10-01)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
by: Dan Lin, et al.
Published: (2021-12-01)

The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation
by: Yingzheng Wang, et al.
Published: (2023-09-01)

Molecular Imaging of Steroid-Induced Osteonecrosis of the Femoral Head through iRGD-Targeted Microbubbles
by: Ping Zhao, et al.
Published: (2022-09-01)

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade
by: Yirong Wu, et al.
Published: (2025-05-01)

Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
by: Jie Shao, et al.
Published: (2024-12-01)

Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells
by: Anna Egorova, et al.
Published: (2022-11-01)

Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy
by: Atieh Yaghoubi, et al.
Published: (2023-07-01)

iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer
by: Hou X, et al.
Published: (2024-08-01)

iRGD Tumor-Penetrating Peptide-Modified Nano-Delivery System Based on a Marine Sulfated Polysaccharide for Enhanced Anti-Tumor Efficiency Against Breast Cancer
by: Chen B, et al.
Published: (2022-02-01)

Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy
by: Congcong Wang, et al.
Published: (2022-05-01)

αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment
by: Prashant Pandey, et al.
Published: (2024-08-01)

Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery
by: Adina Borbély, et al.
Published: (2019-04-01)

The construction of in vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration
by: Xiaotong Yang, et al.
Published: (2020-06-01)

Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy
by: Valeria Sidorenko, et al.
Published: (2024-07-01)

MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization
by: Jouri S. Alanazi, et al.
Published: (2022-01-01)

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial✰
by: J. Lee, et al.
Published: (2023-10-01)

HER-2 Receptor and αvβ3 Integrin Dual-Ligand Surface-Functionalized Liposome for Metastatic Breast Cancer Therapy
by: Dilip Kumar Arya, et al.
Published: (2024-08-01)

Therapeutic and diagnostic implications of exosomes as natural nanoparticles: a new paradigm in brain cancer disease management
by: Shanid Mohiyuddin, et al.
Published: (2025-07-01)

Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in miceResearch in context
by: Christian Schmithals, et al.
Published: (2024-07-01)

Design and synthesis of hydrophobic RGD-peptides derivatives
by: A. V. Dobrynina, et al.
Published: (2010-02-01)

iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis
by: Anna Egorova, et al.
Published: (2023-08-01)

Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues
by: Jordan Cossu, et al.
Published: (2023-02-01)

Enhancing doxorubicin sensitivity in osteosarcoma via iRGD-modified biomimetic nanoparticles targeting MCAM m6A modification
by: Dongjian Song, et al.
Published: (2025-07-01)

The targeted delivery of anti-metastasis oligonucleotide in breast cancer cells by the nanoliposomes conjugated with RGD ligand
by: Farahanaz Kavian Manesh, et al.
Published: (2025-06-01)

RGD peptide-functionalized micelles loaded with crocetin ameliorate doxorubicin-induced cardiotoxicity
by: Ting Wang, et al.
Published: (2025-06-01)

Synthesis and Biological Evaluation of RGD-Conjugated MEK1/2 Kinase Inhibitors for Integrin-Targeted Cancer Therapy
by: Yun Wu, et al.
Published: (2013-11-01)

Endothelial Cell Targeting by cRGD-Functionalized Polymeric Nanoparticles under Static and Flow Conditions
by: Lucía Martínez-Jothar, et al.
Published: (2020-07-01)

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery
by: Xiaolin Yu, et al.
Published: (2021-12-01)

Ultrasound-sensitive cRGD-modified liposomes as a novel drug delivery system
by: Nour M. AlSawaftah, et al.
Published: (2022-12-01)

Construction of the targeted and pH-sensitive paclitaxel drug delivery system RGD/PTX@ZIF-90 and anti-tumor activity research
by: Fei Ge, et al.
Published: (2021-01-01)

Dual-Modality Molecular Imaging of Tumor via Quantum Dots-Liposome–Microbubble Complexes
by: Jieqiong Wang, et al.
Published: (2022-11-01)

Targeting Ultrasmall Gold Nanoparticles with cRGD Peptide Increases the Uptake and Efficacy of Cytotoxic Payload
by: Richard D. Perrins, et al.
Published: (2022-11-01)